Atala Anthony, Koh Chester J
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA.
Annu Rev Biomed Eng. 2004;6:27-40. doi: 10.1146/annurev.bioeng.6.012204.115707.
Few treatment options are available for patients suffering from diseased and injured organs because of a severe shortage of donor organs available for transplantation. Therapeutic cloning, where the nucleus from a donor cell is transferred into an enucleated oocyte in order to extract pluripotent embryonic stem cells, offers a potentially limitless source of cells for replacement therapy. Scientists in the field of tissue engineering apply the principles of cell transplantation, material science, and engineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The present chapter reviews recent advances that have occurred in therapeutic cloning and tissue engineering and describes applications of these new technologies that may offer novel therapies for patients with end-stage organ failure.
由于可用于移植的供体器官严重短缺,患有病变和受伤器官的患者几乎没有治疗选择。治疗性克隆是将供体细胞的细胞核转移到去核卵母细胞中以提取多能胚胎干细胞,为替代疗法提供了潜在的无限细胞来源。组织工程领域的科学家应用细胞移植、材料科学和工程学原理来构建生物替代品,以恢复和维持患病和受伤组织的正常功能。本章回顾了治疗性克隆和组织工程领域的最新进展,并描述了这些新技术的应用,这些应用可能为终末期器官衰竭患者提供新的治疗方法。